Single cell and whole genome amplification product validation of preimplantation genetic testing systems for monogenic disorders
https://doi.org/10.25557/2073-7998.2020.11.63-64
Abstract
About the Authors
E. V. SolovevaRussian Federation
O. R. Kanbekova
Russian Federation
D. I. Zhigalina
Russian Federation
N. A. Skryabin
Russian Federation
L. I. Minaycheva
Russian Federation
References
1. Simpson J.L., Rechitsky S., Kuliev A. Before the beginning: the genetic risk of a couple aiming to conceive. Fertil Steril. 2019;112(4):622-630. doi: 10.1016/j.fertnstert.2019.08.002.
2. Harton G.L., De Rycke M, Fiorentino F. et al. ESHRE PGD consortium best practice guidelines for amplification-based PGD. Human Reproduction. 2011,1: 33-40. doi:10.1093/humrep/deq231.
3. Deans Z., Fiorentino F., Biricik A. et al. The experience of 3 years of external quality assessment of preimplantation genetic diagnosis for cystic fibrosis. European Journal of Human Genetics. 2013;21:800-806. doi: 10.1038/ejhg.2012.244.
Review
For citations:
Soloveva E.V., Kanbekova O.R., Zhigalina D.I., Skryabin N.A., Minaycheva L.I. Single cell and whole genome amplification product validation of preimplantation genetic testing systems for monogenic disorders. Medical Genetics. 2020;19(11):63-64. (In Russ.) https://doi.org/10.25557/2073-7998.2020.11.63-64